Comentario sobre: Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial Sharpe C, Reiner G, Davis S, et al. Pediatrics. 2020;145(6):e20193182 doi: https://doi.org/10.1542/peds.2019-3182

Herrera, Tamara.
Arch. pediatr. Urug ; 92(1): e901, jun. 2021.
Artículo en Español | LILACS-Express | ID: biblio-1248854

Documentos relacionados

  1. [Self-induced epileptic seizures: Prevalence, Causes and Treatment].
  2. [Psychogenic nonepileptic seizures: overview and implications for practice].
  3. [Posttraumatic seizures: a prospective cohort study].
  4. [Dissociative seizures: a manual for neurologists for communicating the diagnosis].
  5. [Neonatal seizures: consider sinus thrombosis].
  6. [Drug-induced seizures: prevalence, risk factors, treatment and prevention].
  7. Effect of early withdrawal of phenobarbitone on the recurrence of neonatal seizures: An open-label randomized controlled trial.
  8. Efficacy and Safety of Phenobarbitone as First-Line Treatment for Neonatal Seizure: A Systematic Review and Meta-Analysis.
  9. [Commentary on: Hand burn injuries in children.]
  10. [Commentary].